| scholarly article | Q13442814 |
| P2093 | author name string | David Zilles | |
| P2860 | cites work | A clinical review of the treatment of catatonia | Q21129101 |
| The polyvagal perspective | Q24684976 | ||
| Vagus nerve stimulation. | Q53095610 | ||
| Catatonia is not schizophrenia and it is treatable. | Q53223801 | ||
| The vagus afferent network: emerging role in translational connectomics | Q57165612 | ||
| Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms | Q77812143 | ||
| VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy | Q85923437 | ||
| Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis | Q89543593 | ||
| Vagus nerve stimulation in ischemic stroke: old wine in a new bottle | Q28243638 | ||
| Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation | Q30947956 | ||
| Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes | Q34723489 | ||
| Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder | Q35723373 | ||
| Electroconvulsive therapy for refractory status epilepticus: A systematic review. | Q35898950 | ||
| "Scared stiff": catatonia as an evolutionary-based fear response | Q35917085 | ||
| Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis | Q36411952 | ||
| Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response? | Q36687563 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. | Q37197224 | ||
| Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients | Q37643885 | ||
| Vagal intimations for catatonia and electroconvulsive therapy | Q38209703 | ||
| Catatonia | Q38851934 | ||
| Vagus nerve stimulation in psychiatry: a systematic review of the available evidence | Q39009743 | ||
| Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia | Q43205095 | ||
| Catatonia: an open prospective series with carbamazepine | Q43767491 | ||
| Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy | Q44568826 | ||
| Electroconvulsive therapy against the patients' will: A case series. | Q47417039 | ||
| A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality | Q47930155 | ||
| Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease | Q48109363 | ||
| EEG Derived Brain Activity Reflects Treatment Response from Vagus Nerve Stimulation in Patients with Epilepsy | Q48485966 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 86 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Vagus Nerve Stimulation as a Treatment for Catatonia: A Hypothesis | |
| P478 | volume | 10 |
Search more.